Literature DB >> 19490416

Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice.

Wing-Kin Syn1, Liu Yang, Dian Jung Chiang, Yue Qian, Youngmi Jung, Gamze Karaca, Steve S Choi, Rafal P Witek, Alessia Omenetti, Thiago A Pereira, Anna Mae Diehl.   

Abstract

OBJECTIVE: To determine how genetic factors might influence the progression of nonalcoholic fatty liver disease (NAFLD). DESIGN/INTERVENTION: Beginning in adolescence, male C57BL6 (BL6) and 129/SVJ mice were fed control (n=15/group) or high-fat (HF) diets (n=30/group) for 6 months. MAIN OUTCOME MEASURES: Assessed were body weight, insulin resistance, hepatic production of free radicals, expression of cytokines and fibrosis-related genes and severity of hepatic steatosis, injury and fibrosis.
RESULTS: High-fat diets induced comparable obesity, hepatic steatosis and insulin resistance in the two strains. Compared with BL6 mice, 129/SVJ mice had impaired induction of antioxidant genes, generated three- to four-fold more free radicals and exhibited two-fold greater induction of profibrogenic cytokines (interleukin-4 and transforming growth factor-beta1) and fibrosis-related genes (fibronectin and tissue inhibitor of metalloproteinase-1) (all P<0.05 for 129 vs BL6). Surprisingly, however, induction of collagen I alpha1 mRNA and accumulation of Sirius red-stained fibrils and hepatic hydroxyproline were similar in BL6 and 129/SVJ mice, and although patchy sinusoidal fibrosis emerged in both strains, neither developed bridging fibrosis.
CONCLUSIONS: Although BL6 and 129/SVJ mice with diet-induced obesity, insulin resistance and steatosis differed with respect to several factors that are thought to influence human NAFLD progression, they developed comparable liver fibrosis. Moreover, none of the risk factors for NAFLD-related cirrhosis in humans, including obesity, insulin resistance, chronic inflammatory and oxidant stress, steatohepatitis or activation of fibrogenic genes, proved to be sufficient to cause cirrhosis in these mice, even when exposure to one or more of these insults was very prolonged.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490416      PMCID: PMC3610179          DOI: 10.1111/j.1478-3231.2009.02036.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  48 in total

Review 1.  Natural history of NAFLD: remarkably benign in the absence of cirrhosis.

Authors:  C P Day
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

2.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

3.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Mark J Soloski; Anna Mae Diehl
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

5.  Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease.

Authors:  Ariel E Feldstein; Bettina G Papouchado; Paul Angulo; Schyler Sanderson; Leon Adams; Gregory J Gores
Journal:  Clin Gastroenterol Hepatol       Date:  2005-04       Impact factor: 11.382

6.  A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats.

Authors:  Michal Carmiel-Haggai; Arthur I Cederbaum; Natalia Nieto
Journal:  FASEB J       Date:  2004-11-02       Impact factor: 5.191

Review 7.  Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-01

Review 8.  Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.

Authors:  Piero Portincasa; Ignazio Grattagliano; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Clin Biochem       Date:  2005-03       Impact factor: 3.281

9.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

10.  Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.

Authors:  M D Weltman; G C Farrell; P Hall; M Ingelman-Sundberg; C Liddle
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

View more
  12 in total

Review 1.  Regulation of DNA glycosylases and their role in limiting disease.

Authors:  Harini Sampath; Amanda K McCullough; R Stephen Lloyd
Journal:  Free Radic Res       Date:  2012-02-06

2.  UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.

Authors:  Soumen K Manna; Andrew D Patterson; Qian Yang; Kristopher W Krausz; Jeffrey R Idle; Albert J Fornace; Frank J Gonzalez
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

3.  Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice.

Authors:  Igor P Pogribny; Athena Starlard-Davenport; Volodymyr P Tryndyak; Tao Han; Sharon A Ross; Ivan Rusyn; Frederick A Beland
Journal:  Lab Invest       Date:  2010-06-14       Impact factor: 5.662

4.  Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.

Authors:  Jamil A Haque; Ryan S McMahan; Jean S Campbell; Masami Shimizu-Albergine; Angela M Wilson; Dianne Botta; Theo K Bammler; Richard P Beyer; Thomas J Montine; Matthew M Yeh; Terrance J Kavanagh; Nelson Fausto
Journal:  Lab Invest       Date:  2010-06-14       Impact factor: 5.662

5.  Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice.

Authors:  Franziska Richter; Lauryn Gabby; Kimberly A McDowell; Caitlyn K Mulligan; Krystal De La Rosa; Pedrom C Sioshansi; Farzad Mortazavi; Ingrid Cely; Larry C Ackerson; Linda Tsan; Niall P Murphy; Nigel T Maidment; Marie-Françoise Chesselet
Journal:  Neurobiol Aging       Date:  2016-12-01       Impact factor: 4.673

6.  Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.

Authors:  Yuwen Luo; Christine M Burrington; Emily C Graff; Jian Zhang; Robert L Judd; Promporn Suksaranjit; Quanhathai Kaewpoowat; Samantha K Davenport; Ann Marie O'Neill; Michael W Greene
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-15       Impact factor: 4.310

7.  Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.

Authors:  Vera H I Fengler; Tanja Macheiner; Sonja M Kessler; Beate Czepukojc; Katja Gemperlein; Rolf Müller; Alexandra K Kiemer; Christoph Magnes; Johannes Haybaeck; Carolin Lackner; Karine Sargsyan
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

8.  Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown-Norway rats.

Authors:  Michael D Roberts; C Brooks Mobley; Ryan G Toedebush; Alexander J Heese; Conan Zhu; Anna E Krieger; Clayton L Cruthirds; Christopher M Lockwood; John C Hofheins; Charles E Wiedmeyer; Heather J Leidy; Frank W Booth; R Scott Rector
Journal:  BMC Gastroenterol       Date:  2015-10-30       Impact factor: 3.067

9.  NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

Authors:  Geoffrey C Farrell; Derrick van Rooyen; Lay Gan; Shivrakumar Chitturi
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

Review 10.  In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).

Authors:  Giridhar Kanuri; Ina Bergheim
Journal:  Int J Mol Sci       Date:  2013-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.